EMILY CUNNINGHAM: Open Payments
NPI 1376141986 · NORTH VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 30 payments from 8 companies in 2025. Trend: 2023 $459 · 2024 $919 · 2025 $1,562
Food & beverage: $1,562
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $446 |
| Janssen Biotech, Inc. | 9 | $353 |
| Ardelyx, Inc. | 5 | $303 |
| ABBVIE INC. | 7 | $236 |
| Phathom Pharmaceuticals, Inc. | 2 | $143 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: REZDIFFRA, TREMFYA, IBSRELA, SKYRIZI, VOQUEZNA, RINVOQ, VOWST, XIFAXAN.
Industry payments across FL — which companies pay providers there.
